Skip to main content
. 2006 Aug;11(3):276–286. doi: 10.1379/CSC-195R.1

Fig 4.

Fig 4.

 Changes of hemostasis parameters due to administration of E coli LPS (dose, 2 mg/kg) depending on concomitant introduction of Hsp70 preparations. 1, E coli LPS (n = 10); 2, Hsp70-ND plus E coli LPS (n = 10); 3, Hsp70-DT plus E coli LPS (n = 10); 4, E coli LPS plus Hsp70-DT (n = 9). *P < 0.05 using Wilcoxon test